Massachusetts Financial Services Co. MA Sells 46,437 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Massachusetts Financial Services Co. MA cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 9.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 438,345 shares of the company’s stock after selling 46,437 shares during the period. Massachusetts Financial Services Co. MA owned about 0.51% of HealthEquity worth $42,059,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter worth approximately $26,000. Smartleaf Asset Management LLC raised its position in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the 4th quarter worth $39,000. UMB Bank n.a. grew its position in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ increased its stake in shares of HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Down 5.0 %

Shares of NASDAQ HQY opened at $78.80 on Friday. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm’s 50-day moving average price is $101.66 and its 200-day moving average price is $96.33.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent research reports. KeyCorp cut their price target on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday, March 24th. Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Finally, Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $112.58.

Read Our Latest Stock Analysis on HQY

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.